CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, Prospective Study of LiverCare
Study to demonstrate utility of LiverCare post-transplant surveillance for liver transplant recipientsSOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the enrollment of the first patient in the Molecular Assessment and Profiling of Liver Tra...
Source: yahoo.com